← Leaderboards
Isabella Claudia Glitza
University Of Tx Md Anderson Can Ctr
$991,518
Attributed
$991,518
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $680K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$991,518 · 2
By mechanism
P50$991,518 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Paul A Scheet$7,895,863
- Michael Davies$11,575,720
- Zhongxing Liao$4,193,578
- Randall E Millikan$529,853
- Ganesh Rao$4,692,231
Others in their field
Other Rising Stars on “Anti-Pd-1”
- Reeder McNeil Robinson · Leukogene Therapeutics, Inc.$2,197,324
- Minah Kim · Columbia University Health Sciences$2,033,782
- Yicheng Wang · Immunova Therapeutics, Llc$2,000,000
- Meenakshi G Hegde · Baylor College Of Medicine$1,938,900
- Christian Hinrichs · Division Of Basic Sciences - Nci$1,566,860
- Sangeeta Goswami · University Of Tx Md Anderson Can Ctr$1,386,369
Research focus
Anti-Pd-1EvaluationAnti-Pd1 TherapyAnti-Tumor Immune ResponseAntibodiesEffective TherapyBreast LymphomaCancer CellCancer TherapyCancer TypeCellsAnti-Pd1 AntibodiesCentral Nervous System DiseasesBloodCerebrospinal FluidClinical DiagnosisClinical TrialsComplicationCytokineCytologyDesignDiagnosisDisorder ControlExhibits
Grant awards (2)
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)$680,004
P50 · FY2023 · CA · contact PI
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)$311,514
P50 · FY2022 · CA · contact PI